Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Etanercept given every week subcutaneously Adalimumab given every 2 weeks subcutaneously Infliximab given every 6 to 8 weeks intravenously Certolizumab pegol given every 2 to 4 weeks subcutaneously Golimumab given monthly subcutaneously Simponi ARIA given every 8 weeks intravenously There are other, less common biologic agents that can interrupt the inflammatory process, including: Tocilizumab (Actemra) Sarilumab (Kevzara) Abatacept (Orencia) These too, are given either subcutaneously or through IV every few weeks
Read more about these FDA concerns here
Self-sourcing unregulated product
Products sold on XcelPeptides.com are for laboratory research only and are not intended for diagnostic, clinical, animal, or human use
Both peptides are prohibited by WADA under category S0 (Unapproved Substances)
This content must not be interpreted as medical advice, nor should it be construed to encourage self-administration or any human use of the substances discussed
US$ 24.28
US$ 22.76
US$ 23.26